Even though a lot of people are injecting exosomes in the scalp they are not FDA-cleared, so if something happens to a patient, you dont have a leg to stand on. In its most recent statement on regenerative medicine products, the FDA made it very clear it is not yet on board with this technology: Exosome products are regulated by the FDA and there are currently no FDA-approved exosome products. In contrast to exosomes, platelet-rich plasma (PRP) is separated from your own blood in a centrifuge before it is injected back into your scalp
No metabolic effects on breast-fed newborn/infant are anticipated as insulin glargine is digested into amino acids in the gastrointestinal tract
it is supplied as a chemical reagent for laboratory use
Similar findings have been made in evaluations of patients with PD [28,29,30]
Un paciente con diabetes que tambin intenta dejar de fumar podra razonablemente elegir un GLP-1 en lugar de otro medicamento para reducir la glucosa, no porque est aprobado para dejar el tabaco, sino porque podra ayudarle a lograrlo, un beneficio que otros frmacos para la diabetes no ofrecen
10.29219/fnr.v64.4751 30